Format
Sort by
Items per page

Send to

Choose Destination

Best matches for adhd impp2l:

Search results

Items: 1 to 20 of 35974

  • The following term was not found in PubMed: impp2l.
1.

Association of Primary Care Consultation Patterns With Early Signs and Symptoms of Psychosis.

Sullivan SA, Hamilton W, Tilling K, Redaniel T, Moran P, Lewis G.

JAMA Netw Open. 2018 Nov 2;1(7):e185174. doi: 10.1001/jamanetworkopen.2018.5174.

PMID:
30646393
2.

Association of Childhood Social-Emotional Functioning Profiles at School Entry With Early-Onset Mental Health Conditions.

Thomson KC, Richardson CG, Gadermann AM, Emerson SD, Shoveller J, Guhn M.

JAMA Netw Open. 2019 Jan 4;2(1):e186694. doi: 10.1001/jamanetworkopen.2018.6694.

PMID:
30646194
3.

Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.

Christensen J, Pedersen LH, Sun Y, Dreier JW, Brikell I, Dalsgaard S.

JAMA Netw Open. 2019 Jan 4;2(1):e186606. doi: 10.1001/jamanetworkopen.2018.6606.

PMID:
30646190
4.

Fetal Valproate Exposure and Attention-Deficit/Hyperactivity Disorder.

Meador KJ.

JAMA Netw Open. 2019 Jan 4;2(1):e186603. doi: 10.1001/jamanetworkopen.2018.6603. No abstract available.

PMID:
30646187
5.

Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016.

Xu G, Strathearn L, Liu B, Yang B, Bao W.

JAMA Netw Open. 2018 Aug 3;1(4):e181471. doi: 10.1001/jamanetworkopen.2018.1471.

PMID:
30646132
6.

Paying Attention to Attention-Deficit/Hyperactivity Disorder.

Dickstein DP.

JAMA Netw Open. 2018 Aug 3;1(4):e181504. doi: 10.1001/jamanetworkopen.2018.1504. No abstract available.

PMID:
30646125
7.

Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.

Wei YJ, Zhu Y, Liu W, Bussing R, Winterstein AG.

JAMA Netw Open. 2018 Aug 3;1(4):e181152. doi: 10.1001/jamanetworkopen.2018.1152.

PMID:
30646105
8.

Risk factors for the difficulties in general activities across the day in Chinese children and adolescents with attention-deficit/hyperactivity disorder.

Ke X, Du Y, Zheng Y, Su L, Chen Y, Zhang Y, Chen K, Cheng Y, Chen W.

Neuropsychiatr Dis Treat. 2018 Dec 31;15:157-166. doi: 10.2147/NDT.S187882. eCollection 2019.

PMID:
30643414
9.

Effect of Taekwondo Practice on Cognitive Function in Adolescents with Attention Deficit Hyperactivity Disorder.

Kadri A, Slimani M, Bragazzi NL, Tod D, Azaiez F.

Int J Environ Res Public Health. 2019 Jan 12;16(2). pii: E204. doi: 10.3390/ijerph16020204.

PMID:
30642062
10.

Adulthood and childhood ADHD in patients consulting for obesity is associated with food addiction and binge eating, but not sleep apnea syndrome.

Brunault P, Frammery J, Montaudon P, De Luca A, Hankard R, Ducluzeau Pierre-Henri PH, Cortese S, Ballon Nicolas N.

Appetite. 2019 Jan 11. pii: S0195-6663(18)31308-4. doi: 10.1016/j.appet.2019.01.013. [Epub ahead of print]

PMID:
30641157
11.

High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.

Golubchik P, Shalev L, Tsamir D, Manor I, Weizman A.

Int Clin Psychopharmacol. 2019 Jan 11. doi: 10.1097/YIC.0000000000000252. [Epub ahead of print]

PMID:
30640748
12.

Specificity of expectancies prospectively predicting alcohol and marijuana use in adulthood in the Pittsburgh ADHD longitudinal study.

Walther CAP, Pedersen SL, Gnagy E, Pelham WE, Molina BSG.

Psychol Addict Behav. 2019 Jan 14. doi: 10.1037/adb0000439. [Epub ahead of print]

PMID:
30640503
13.

Association of Tourette Syndrome and Chronic Tic Disorder With Metabolic and Cardiovascular Disorders.

Brander G, Isomura K, Chang Z, Kuja-Halkola R, Almqvist C, Larsson H, Mataix-Cols D, Fernández de la Cruz L.

JAMA Neurol. 2019 Jan 14. doi: 10.1001/jamaneurol.2018.4279. [Epub ahead of print]

PMID:
30640363
14.

Aural and nasal foreign bodies in children - Epidemiology and correlation with hyperkinetic disorders, developmental disorders and congenital malformations.

Schuldt T, Großmann W, Weiss NM, Ovari A, Mlynski R, Schraven SP.

Int J Pediatr Otorhinolaryngol. 2019 Jan 7;118:165-169. doi: 10.1016/j.ijporl.2019.01.006. [Epub ahead of print]

PMID:
30639970
15.

Transdiagnostic neuroimaging in psychiatry: A review.

Mitelman SA.

Psychiatry Res. 2019 Jan 8. pii: S0165-1781(18)32084-5. doi: 10.1016/j.psychres.2019.01.026. [Epub ahead of print] Review.

PMID:
30639090
16.

Prescription stimulant misuse avoidance self-efficacy: Correlates and moderation by race/ethnicity.

Figueroa W, Yomogida K, Mendez J, Bavarian N.

J Ethn Subst Abuse. 2019 Jan 14:1-14. doi: 10.1080/15332640.2018.1542370. [Epub ahead of print]

PMID:
30638147
17.

ADHD risk genes involved in dopamine signaling and metabolism are associated with reduced estimated life expectancy at young adult follow-up in hyperactive and control children.

Barkley RA, Smith KM, Fischer M.

Am J Med Genet B Neuropsychiatr Genet. 2019 Jan 13. doi: 10.1002/ajmg.b.32711. [Epub ahead of print]

PMID:
30637915
18.

A cohort study to identify and evaluate concussion risk factors across multiple injury settings: findings from the CARE Consortium.

Van Pelt KL, Allred D, Cameron KL, Campbell DE, D'Lauro CJ, He X, Houston MN, Johnson BR, Kelly TF, McGinty G, Meehan S, O'Donnell PG, Peck KY, Svoboda SJ, Pasquina P, McAllister T, McCrea M, Broglio SP.

Inj Epidemiol. 2019 Jan 14;6(1):1. doi: 10.1186/s40621-018-0178-3.

PMID:
30637568
19.

Evaluating the relationship between adult attention-deficit/hyperactivity disorder and riding behavior of motorcyclists.

Sadeghi-Bazargani H, Hasanzadeh K, Salarylak S, Amiri S, Golestani M, Shahedifar N.

J Inj Violence Res. 2019 Jan 12;11(1). doi: 10.5249/jivr.v11i1.1098. [Epub ahead of print]

20.

Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhance sustained attention.

Marshall CA, Brodnik ZD, Mortensen OV, Reith MEA, Shumsky JS, Waterhouse BD, España RA, Kortagere S.

Neuropharmacology. 2019 Jan 8. pii: S0028-3908(19)30002-4. doi: 10.1016/j.neuropharm.2019.01.003. [Epub ahead of print]

PMID:
30633928

Supplemental Content

Loading ...
Support Center